SUBSTITUTED 1,5-NAPHTHYRIDINE AZOLIDINONES AS CDK INHIBITORS
申请人:F. Hoffmann-La Roche AG
公开号:EP1869036B1
公开(公告)日:2010-11-03
US7304074B2
申请人:——
公开号:US7304074B2
公开(公告)日:2007-12-04
[EN] SUBSTITUTED 1,5-NAPHTHYRIDINE AZOLIDINONES AS CDK INHIBITORS<br/>[FR] 1,5-NAPHTYRIDINEAZOLIDINONES SUBSTITUÉES EN TANT QU'AGENTS INHIBITEURS DE CDK
申请人:HOFFMANN LA ROCHE
公开号:WO2006106046A1
公开(公告)日:2006-10-12
[EN] The present invention provides novel, substituted 1,5-naphthyridine azolinones of formula (I) which inhibit Cdkl and are selective against Cdk2 and Cdk4. These compounds and their pharmaceutically acceptable salts have antiproliferative activity and are useful as anti-cancer agents. [FR] La présente invention concerne de nouvelles 1,5-naphtyridineazolidinones substituées de formule (I) qui inhibent CdkI et sont sélectives vis-à-vis de Cdk2 et Cdk4. Ces composés et leurs sels de qualité pharmaceutique présentent une activité antiproliférative et peuvent être employés en tant qu'agents anticancéreux.
Substituted 1,5-naphthyridine azolinones
申请人:Liu Jin-Jun
公开号:US20060223843A1
公开(公告)日:2006-10-05
Substituted 1,5-naphthyridine azolinones inhibit Cdk1 and are selective against Cdk2 and Cdk4. These compounds and their pharmaceutically acceptable salts have antiproliferative activity and are useful as anti-cancer agents.